Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Telesis Bio Inc. (TBIO) had Revenue of $27.51M for the most recently reported fiscal year, ending 2023-12-31.

Quarterly Annual

Figures for fiscal year ending 2023-12-31

Income Statement Financials
Revenue	$27.51M
Net Income	$-49.02M
Cost of Goods Sold	$10.56M
Gross Profit	$16.95M
Operating Expenses	$74.05M
Operating Income	$-46.54M
Non-Operating Income/Expense	$-1.16M
Pre-Tax Income	$-47.70M
Normalized Pre-Tax Income	$-47.70M
Income after Taxes	$-47.72M
Income from Continuous Operations	$-47.72M
Consolidated Net Income/Loss	$-47.72M
Normalized Income after Taxes	$-47.72M
EBIT	$-46.54M
EBITDA	$-30.28M
Weighted-Average Shares Outstanding (Basic)	1.66M
Weighted-Average Shares Outstanding (Diluted)	1.66M
Earnings per Share (EPS) (Basic)	$-29.50
Earnings per Share (EPS) (Diluted)	$-29.50
Balance Sheet Financials
Current Assets	$30.35M
Property, Plant, and Equipment	$7.30M
Long-Term Assets	$40.06M
Total Assets	$70.41M
Current Liabilities	$8.18M
Long-Term Debt	$5.42M
Long-Term Liabilities	$61.99M
Total Liabilities	$70.17M
Common Equity	$0.24M
Tangible Shareholders Equity	$-4.63M
Shareholders Equity	$0.24M
Common Shares Outstanding	1.67M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-34.67M
Cash Flow from Investing Activities	$-5.74M
Cash Flow from Financial Activities	$11.56M
Beginning Cash	$30.59M
End Cash	$1.75M
Increase/Decrease in Cash	$-28.85M
Stock-Based Compensation	$3.96M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.71
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.96
Debt to Equity Ratio	23.23
Gross Margin	61.62%
Operating Margin	-169.18%
EBIT Margin	-169.18%
EBITDA Margin	-110.08%
Pre-Tax Profit Margin	-173.40%
Profit Margin	-178.21%
Free Cash Flow	$-36.63M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.39
Inventory Turnover	2.62
Receiveable Turnover	4.60
Days Sales in Receivables	79.41
Return on Equity	-20051.54%
Return on Tangible Equity	1031.65%
Return on Assets	-67.78%
Return on Investments	-844.08%
Book Value Per Share	$0.14
Free Cash Flow per Share	$-22.07
Operating Cash Flow per Share	$-20.89

Data from Zacks Investment Research, Inc.